zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2(5):342–50.
Article
CAS
PubMed
Google Scholar
Burd EM. Human Papillomavirus and cervical cancer. Clin Microbiol Rev. 2003;16(1):1–17.
Article
CAS
PubMed
PubMed Central
Google Scholar
Denny LA, et al. Human papillomavirus, human immunodeficiency virus and immunosuppression. Vaccine. 2012;30(Suppl 5):F168–74.
Article
CAS
PubMed
Google Scholar
Meyrelles ARI, et al. Bonafide, type-specific human papillomavirus persistence among HIV-positive pregnant women: predictive value for cytological abnormalities, a longitudinal cohort study. Mem Inst Oswaldo Cruz. 2016;111(2):120–7.
Article
PubMed
PubMed Central
Google Scholar
Grinsztejn B, et al. Factors associated with increased prevalence of human papillomavirus infection in a cohort of HIV-infected Brazilian women. Int J Infect Dis. 2009;13(1):72–80.
Article
PubMed
Google Scholar
Konopnicki D, et al. Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women. J Infect Dis. 2013;207(11):1723–9.
Article
CAS
PubMed
Google Scholar
Blitz S, et al. Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women. J Infect Dis. 2013;208(3):454–62.
Article
CAS
PubMed
Google Scholar
Adler DH, et al. Increased regression and decreased incidence of human papillomavirus- related cervical lesions among HIV-infected women on HAART. AIDS. 2012;26(13):1645–52.
Article
PubMed
PubMed Central
Google Scholar
Firnhaber C, et al. Highly active antiretroviral therapy and cervical dysplasia in HIV-positive women in South Africa. J Int AIDS Soc. 2012;15(2):17382.
Article
PubMed
PubMed Central
Google Scholar
Minkoff H, et al. Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Infect Dis. 2010;201(5):681–90.
Article
PubMed
PubMed Central
Google Scholar
Konopnicki D, De Wit S, Clumeck N. HPV and HIV coinfection: a complex interaction resulting in epidemiological, clinical and therapeutic implications. Futur Virol. 2013;8(9):903–15.
Article
CAS
Google Scholar
De Vuyst H, et al. Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya. Br J Cancer. 2012;107(9):1624–30.
Article
CAS
PubMed
PubMed Central
Google Scholar
Firnhaber C, et al. Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa. Cancer Causes Control. 2010;21(3):433–43.
Article
PubMed
Google Scholar
Watson-Jones D, et al. High prevalence and incidence of human papillomavirus in a cohort of healthy young African female subjects. Sex Transm Infect. 2013;89(5):358–65.
Article
PubMed
PubMed Central
Google Scholar
Asiaf A, et al. Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection. Eur J Cancer Prev. 2014;23(3):206–24.
Article
CAS
PubMed
Google Scholar
Carozzi F, et al. Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalence. J Clin Virol. 2014;60:257–63.
Article
PubMed
Google Scholar
Gadducci A, et al. Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature. Gynecol Endocrinol. 2011;27(8):597–604.
Article
PubMed
Google Scholar
Appleby P, et al. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet. 2007;370(9599):1609–21.
Article
PubMed
Google Scholar
Moreno V, et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet. 2002;359(9312):1085–92.
Article
CAS
PubMed
Google Scholar
Shew ML, et al. Association of Chlamydia trachomatis infection with redetection of human papillomavirus after apparent clearance. J Infect Dis. 2013;208(9):1416–21.
Article
PubMed
PubMed Central
Google Scholar
Paba P, et al. Co-expression of HSV2 and Chlamydia trachomatis in HPV-positive cervical cancer and cervical intraepithelial neoplasia lesions is associated with aberrations in key intracellular pathways. Intervirology. 2008;51(4):230–4.
Article
CAS
PubMed
Google Scholar
Bosch FX, Albero G, Castellsague X. Male circumcision, human papillomavirus and cervical cancer: from evidence to intervention. J Fam Plann Reprod Health Care. 2009;35(1):5–7.
Article
PubMed
Google Scholar
Forman D, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30(Suppl 5):F12–23.
Article
PubMed
Google Scholar
Brandful JAM, et al. Oncogenic human papillomavirus (HPV) in women from Ghana. J Cancer Res Exp Oncol. 2014;6(4):31–8.
Google Scholar
Attoh S, et al. Human papilloma virus genotypes in Ghanaian women with cervical carcinoma. East Afr Med J. 2010;87(8):345–9.
CAS
PubMed
Google Scholar
Quentin W, et al. Costs of cervical cancer screening and treatment using visual inspection with acetic acid (VIA) and cryotherapy in Ghana: the importance of scale. Tropical Med Int Health. 2011;16(3):379–89.
Article
Google Scholar
de Sanjose S, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048–56.
Article
CAS
PubMed
Google Scholar
Group, T.F.I.S. Quadrivalent vaccine against human Papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007;356(19):1915–27.
Article
Google Scholar
Joura EA, et al. A 9-Valent HPV vaccine against infection and intraepithelial Neoplasia in women. N Engl J Med. 2015;372(8):711–23.
Article
CAS
PubMed
Google Scholar
Harper DM, Williams KB. Prophylactic HPV vaccines: current knowledge of impact on gynecologic premalignancies. Discov Med. 2010;10(50):7–17.
PubMed
Google Scholar
Bouvard V, et al. A review of human carcinogens; part B: biological agents. Lancet Oncol. 2009;10(4):321–2.
Article
PubMed
Google Scholar
Kwon MJ, et al. Comparison of the Anyplex II HPV28 assay with the hybrid capture 2 assay for the detection of HPV infection. J Clin Virol. 2014;59:246–9.
Article
CAS
PubMed
Google Scholar
Solomon D, et al. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA. 2002;287(16):2114–9.
Article
PubMed
Google Scholar
Darragh TM, et al. The lower Anogenital Squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Low Genit Tract Dis. 2012;16(3):205–42.
Article
PubMed
Google Scholar
Park EK, et al. Human Papillomavirus prevalence and genotype distribution among HIV-infected women in Korea. J Korean Med Sci. 2014;29(1):32–7.
Article
PubMed
Google Scholar
Ezechi OC, et al. The burden, distribution and risk factors for cervical oncogenic human papilloma virus infection in HIV positive Nigerian women. Virol J. 2014;11(1):5.
Article
PubMed
PubMed Central
Google Scholar
Didelot-Rousseau MN, et al. Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. Br J Cancer. 2006;95(3):355–62.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mbulawa ZZ, et al. Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection. J Infect Dis. 2009;199(10):1514–24.
Article
PubMed
Google Scholar
Rebolj M, et al. Disagreement between human Papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening. PLoS One. 2014;9(1):e86835.
Article
PubMed
PubMed Central
Google Scholar
Lowy DR, et al. Human papillomavirus infection and the primary and secondary prevention of cervical cancer. Cancer. 2008;113(7 Suppl):1980–93.
Article
PubMed
Google Scholar
Roden R, et al. Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition. J Virol. 1996;70:3298–301.
CAS
PubMed
PubMed Central
Google Scholar
Anastasiou-Fotaki P, Deligeoroglou E, Kreatsas G. The GARDASIL vaccine can prevent cervical carcinoma caused by human papilloma virus (HPV) (results from our participation and from the study carried out in Greece). Akush Ginekol (Sofiia). 2007;46(3):17–20.
Google Scholar
Fairley CK, et al. Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women. Sex Transm Infect. 2009;85(7):499–502.
Article
CAS
PubMed
Google Scholar
de Sanjose S, et al. Age-specific occurrence of HPV16- and HPV18-related cervical cancer. Cancer Epidemiol Biomark Prev. 2013;22(7):1313–8.
Article
CAS
Google Scholar
van Aardt MC, et al. Unique human Papillomavirus-type distribution in south African women with invasive cervical cancer and the effect of human immunodeficiency virus infection. Int J Gynecol Cancer. 2015;25:919.
Article
PubMed
Google Scholar
Pirek D, et al. Human papillomavirus genotype distribution among Cameroonian women with invasive cervical cancer: a retrospective study. Sex Transm Infect. 2015;91:440.
Article
PubMed
Google Scholar
Maranga IO, et al. HIV infection alters the Spectrum of HPV subtypes found in cervical smears and carcinomas from Kenyan women. Open Virol J. 2013;7:19.
Article
PubMed
PubMed Central
Google Scholar
Denny L, et al. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa. Int J Cancer. 2014;134(6):1389–98.
Article
CAS
PubMed
Google Scholar
Mitchell SM, et al. Factors associated with high-risk HPV positivity in a low-resource setting in sub-Saharan Africa. Am J Obstet Gynecol. 2014;210(1):81. e1-81.e7
Article
PubMed
Google Scholar
Louie KS, de Sanjose S, Mayaud P. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review. Tropical Med Int Health. 2009;14(10):1287–302.
Article
Google Scholar
Domfeh A, et al. Cervical human papillomavirus infection in Accra, Ghana. Ghana Med J. 2008;42(2):71–8.
PubMed
PubMed Central
Google Scholar
Brankovic I, Verdonk P, Klinge I. Applying a gender lens on human papillomavirus infection: cervical cancer screening, HPV DNA testing, and HPV vaccination. Int J Equity Health. 2013;12:14.
Article
PubMed
PubMed Central
Google Scholar
Handlogten KS, et al. Cervical cancer screening in Ghana, west Africa: prevalence of abnormal cytology and challenges for expanding screening. Int J Gynecol Pathol. 2014;33(2):197–202.
Article
PubMed
Google Scholar
Hood JE, et al. The association between HPV, intraepithelial lesions and HIV-1 shedding in anogenital specimens in two contrasting populations: Senegalese women and American MSM. Int J STD AIDS. 2015;27(5):353–62.
McKenzie KP, et al. Cervical squamous intraepithelial lesions among HIV-positive women on antiretroviral therapy in Kenya. Curr HIV Res. 2011;9(3):180–5.
Article
CAS
PubMed
Google Scholar
Moodley JR, et al. Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study. BMC Cancer. 2009;9:275.
Article
PubMed
PubMed Central
Google Scholar